MDPI and ACS Style
Shi, Y.; Xu, H.; Raynor, W.Y.; Ding, J.; Lin, L.; Zhou, C.; Wang, W.; Meng, Y.; Wu, X.; Chen, X.;
et al. Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study. Life 2022, 12, 1954.
https://doi.org/10.3390/life12121954
AMA Style
Shi Y, Xu H, Raynor WY, Ding J, Lin L, Zhou C, Wang W, Meng Y, Wu X, Chen X,
et al. Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study. Life. 2022; 12(12):1954.
https://doi.org/10.3390/life12121954
Chicago/Turabian Style
Shi, Yangyang, Hailing Xu, William Y. Raynor, Jiapei Ding, Ling Lin, Chao Zhou, Wei Wang, Yinnan Meng, Xiaomai Wu, Xiaofeng Chen,
and et al. 2022. "Efficacy and Failure Patterns of Early SBRT to the Primary Tumor in Advanced EGFR-Mutation-Positive Lung Cancer with EFGR-TKI Treatment: A Prospective, Single Arm, Phase II Study" Life 12, no. 12: 1954.
https://doi.org/10.3390/life12121954